![Alex Dasalla](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Alex Dasalla is currently the Head of Investor Relations & Corporate Communications at Aura Biosciences, Inc. since 2022.
Prior to this, he held the same position at Collegium Pharmaceutical, Inc. from 2017 to 2022.
Postes actifs de Alex Dasalla
| Sociétés | Poste | Début |
|---|---|---|
| AURA BIOSCIENCES, INC. | Investor Relations Contact | 01/09/2022 |
Anciens postes connus de Alex Dasalla
| Sociétés | Poste | Fin |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Public Communications Contact | 01/09/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
